A recent review published in the journal Biomolecules discussed the potential uses of melatonin in treating brain fog and chronic fatigue syndrome or myalgic encephalomyelitis symptoms associated with long coronavirus disease (COVID).  

 

Psoriasis is a chronic, inflammatory skin disease that affects about one in 40 people, making it “one of the most frequent chronic skin diseases worldwide.” 

 

There are a lot of different drugs for it, some of which cost more than $100k a year to get a response. There are cheaper ones, like cyclosporine, but they carry long-term risks. 

 

In fact, cyclosporine can cause cancer and kidney toxicity in more than 50 percent of the patients treated long-term, and, in terms of risk of malignancies, it carries up to 42 times the rate of cancer.  

 

There’s got to be a better way.